share_log

汇宇制药(688553.SH):普乐沙福注射液、注射用阿扎胞苷、注射用塞替派分别获得以色列、埃及、北爱尔兰上市许可

Huayu Pharmaceuticals (688553.SH): Plerixafor injection, Azacitidine for injection, and Setipiprant for injection have been granted market approval in Israel, Egypt, and Northern Ireland, respectively.

Gelonghui Finance ·  Aug 27 05:14

Gelonghui August 27th 丨 Huayu Pharmaceutical (688553.SH) announced that its wholly-owned subsidiary Seacross Pharmaceuticals Ltd. recently received market approval for the company's products Pulisafu Injection, Azacitidine for Injection, and Cetuximab for Injection issued by the Israeli Ministry of Health, Egyptian Drug Authority, and the United Kingdom Medicines and Healthcare Products Regulatory Agency respectively.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment